Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
IT1-H5213 | Human | Human Integrin alpha V beta 1 (ITGAV&ITGB1) Heterodimer Protein, Tag Free&Tag Free | ![]() |
![]() ![]() |
![]() ![]() |
IT1-H82W6 | Human | Biotinylated Human Integrin alpha V beta 1 (ITGAV&ITGB1) Heterodimer Protein, His,Avitag™&Tag Free | ![]() |
![]() ![]() |
![]() ![]() |
IT1-H52E1 | Human | Human Integrin alpha V beta 1 (ITGAV&ITGB1) Heterodimer Protein, His Tag&Tag Free | ![]() |
![]() ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
PLN-1474 | PLN-1474 | Phase 1 Clinical | Pliant Therapeutics Inc, Novartis Pharma Ag | Non-alcoholic Fatty Liver Disease; Liver Cirrhosis | Details |
IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Non-alcoholic Fatty Liver Disease; Idiopathic Pulmonary Fibrosis | Details |
PLN-74809 | PLN-74809 | Phase 2 Clinical | Pliant Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing | Details |
This web search service is supported by Google Inc.